Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
about
Gene expression of sternohyoid and diaphragm muscles in type 2 diabetic rats.Adipose tissue and vascular inflammation in coronary artery disease.Apelin-13 decreases lipid storage in hypertrophic adipocytes in vitro through the upregulation of AQP7 expression by the PI3K signaling pathwayDoes polycystic ovary syndrome itself have additional effect on apelin levels?Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus.Apelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ.Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue.Apelin and insulin resistance: another arrow for the quiver?Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.Treatment with metformin and a dipeptidyl peptidase-4 inhibitor elevates apelin levels in patients with type 2 diabetes mellitus.Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis.The impact of aerobic exercise training on novel adipokines, apelin and ghrelin, in patients with type 2 diabetesAbnormal fluid homeostasis in apelin receptor knockout miceAssociations between serum apelin-12 levels and obesity-related markers in Chinese childrenAdipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.Apelin, diabetes, and obesity.Biomarkers in the field of obesity and its related comorbidities.Therapeutic implications of peptide interactions with G-protein-coupled receptors in diabetic vasculopathy.Plasma apelin and ADMA Levels in patients with essential hypertension.Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges.Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptorBlockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes.Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.Correlation between plasma levels of apelin and myocardial hypertrophy in rats and humans: possible target for treatment?Apelin and G212A apelin receptor gene polymorphism in obese and diabese youth.Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects.Apelin-13 inhibits gastric motility through vagal cholinergic pathway in rats.Apelin, Nitric Oxide and Vascular Affection in Adolescent Type 1 Diabetic Patients.Downregulation of the Apelinergic Axis Accelerates Aging, whereas Its Systemic Restoration Improves the Mammalian Healthspan.Circulating apelin levels are associated with cardiometabolic risk factors in women with previous gestational diabetes.Recognition of the polycistronic nature of human genes is critical to understanding the genotype-phenotype relationship.
P2860
Q31143158-FBF28EF3-30C3-4F66-9B5F-DB7817DFB8D4Q33948483-6BBB1938-FE7A-45FF-90BD-5360733A5526Q34062141-0DDD0BF2-A9AD-4F40-811C-79434B776D03Q34390789-630184C1-E33D-4B49-A325-FE7AD5BA11F6Q34507329-8BD9FB8E-D470-4898-AAE8-DFB20628F917Q34600236-7BAED5B1-0EE6-44DE-9607-0EFE4EE29507Q34866320-5694CA20-FA94-48C7-B709-AC47915E8483Q35114027-20A7D88B-C95C-4FB6-B356-D7DC3F3EA87FQ35166911-DFB22517-8D36-46DD-9441-D871EE07A239Q35829203-4048DAF9-3B91-448A-A8CE-4CBDC1D9A1C8Q35982134-F14B9BC7-082E-4CC9-B7E7-C81C71FB619AQ36167351-A617F8B0-02A0-4E54-816C-2E809B991588Q36577023-31D9BD09-18B5-4ED8-8E0C-4C37ED4D7317Q37312820-D57FE00E-2323-4582-9EBA-3EC3B6F2F197Q37520837-56ECC2F8-9DE8-492D-B5F8-D32F204A4EDBQ37686803-39C787FD-1604-4768-9597-58623A53E430Q37897155-C0184DC0-54EF-437F-B8D3-9847705258B3Q38183431-1371CA98-6545-4B6B-80FF-598AB61F7391Q38196857-BF8ED630-AF25-4A0A-AC65-F38E4B56AF6BQ39869419-5BDB19CA-8990-4577-8258-57AE211B9B39Q42124925-8130157E-88F7-4043-B8FA-249AF6DFE42EQ42715690-CD2EE639-749C-4BF8-B243-6E918A5EEFD5Q42816993-4B0956CC-1AE1-4743-B9C6-5FB0CB0B6553Q43127253-789D97F6-E8ED-4216-8DD0-BDD1087B9117Q43200440-F1D19D16-699E-41E9-A38F-664425975204Q43538212-EEECE604-BBEA-4E7F-AA06-596E11BDAAD6Q47806448-09BA4FBD-4ED9-4244-86A6-8F7B90080D6CQ48021692-E241FF53-4D85-4E5A-A5AA-2FACCE659984Q49163329-D5300633-11F2-4F6D-B516-791FE118BE8EQ50104995-C9F0B19E-D0BF-4581-B373-411C1A8FA750Q51331927-3FCED9D9-CF35-4E15-A77B-4C22ABE93B8BQ52601702-2D17B6B5-AECC-45B2-9C26-365D4C43106D
P2860
Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
@en
Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
@nl
type
label
Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
@en
Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
@nl
prefLabel
Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
@en
Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
@nl
P2093
P356
P1476
Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
@en
P2093
P304
P356
10.1055/S-2007-1004564
P577
2008-05-01T00:00:00Z